In Stock
Mycophenolate Mofetil Tablets IP
Mycophenolate Mofetil Tablets IP are immunosuppressive medicines used to help prevent organ transplant rejection by reducing excessive immune system activity.
Product Details
Mycophenolate Mofetil Tablets IP contain mycophenolate mofetil, an immunosuppressive medicine commonly used with other medicines to prevent rejection following organ transplantation. It reduces the activity of certain immune cells, helping protect the transplanted organ from an excessive immune response.
Key Benefits
- Helps prevent rejection of transplanted organs
- Supports long-term transplant management
- Reduces excessive immune system activity
- Helps protect transplanted organs from immune-mediated damage
- May be used as part of combination immunosuppressive therapy
How It Works
Mycophenolate mofetil is converted in the body to mycophenolic acid, which inhibits an enzyme required for the production of certain nucleotides in lymphocytes. This limits the growth and activity of T and B lymphocytes and reduces the immune response responsible for transplant rejection.
Common Side Effects
- Diarrhea
- Nausea
- Vomiting
- Abdominal discomfort
- Headache
- Fatigue
- Increased risk of infections
- Reduced blood cell counts
Important Information
Mycophenolate Mofetil Tablets IP should be used strictly under the supervision of a qualified transplant specialist. It can significantly suppress the immune system and increase the risk of serious infections and certain cancers. Regular blood tests may be required to monitor blood cell counts, liver function, and other parameters. Mycophenolate can cause serious birth defects and pregnancy loss; appropriate pregnancy-prevention measures and medical guidance are essential for patients who can become pregnant. Do not stop treatment or change the dose without medical advice.
